Pharma Intelligence

CRISPR-based cancer therapies likely to be a disruptive technology in healthcare:  GlobalData

Read more

China continues to lead high value oncology deals in APAC: GlobalData

Read more

Is Women’s Health gaining momentum?

Read more

COVID-19 expedites India’s focus on innovation within pharma: GlobalData 

Read more

India’s CMO market is hotbed­­­ for global PE investment: GlobalData

Read more

COVID-19 effect will boost infectious disease drug approvals

Read more